All Stories

  1. Central Diabetes Insipidus in a Patient With Lymphoma: A Case Report
  2. Clinical pharmacology of glucagon-like peptide-1 receptor agonists
  3. Recovery of reproductive function following androgen abuse
  4. Subacute thyroiditis in a patient with Epstein-Barr virus (EBV) meningitis
  5. Preface
  6. Conclusions and Future Trends
  7. Adaptive Glucose Prediction Models
  8. Nonlinear Models of Glucose Concentration
  9. Prediction Models of Hypoglycemia
  10. Physiological Models and Exogenous Input Modeling
  11. Existing and Potential Applications of Glucose Prediction Models
  12. Pathophysiology and Management of Type 1 Diabetes
  13. Background and Preview
  14. Methodology for Developing a Glucose Prediction Model
  15. Linear Time Series Models of Glucose Concentration
  16. Familial partial lipodystrophy and proteinuric renal disease
  17. Effects of anabolic androgenic steroids on the reproductive system of athletes
  18. Inhibin B levels and bone health in male adult patients with Type 1 Diabetes Mellitus
  19. Serum vitamin D in overweight patients with normal and impaired GFR
  20. SP385VITAMIN D IN OVERWEIGHT CHRONIC KIDNEY DISEASE PATIENTS
  21. Effects of Anabolic Androgenic Steroids on the Reproductive System of Athletes and Recreational Users: A Systematic Review and Meta-Analysis
  22. Choroidal metastasis from papillary thyroid cancer: An unusual feature of a common disease
  23. Denosumab is a long-term option for the management of parathyroid carcinoma-related refractory hypercalcemia
  24. Clinical and imaging evaluation of the response to intravenous steroids in patients with Graves’ orbitopathy and analysis on who requires additional therapy
  25. The ongoing challenge of discrepant growth hormone and insulin-like growth factor I results in the evaluation of treated acromegalic patients: a systematic review and meta-analysis
  26. Prolactin levels in drug-naïve patients with schizophrenia and other psychotic disorders
  27. The influence of glycemic control on bone mineral density and bone metabolism in patients with Type 2 Diabetes Mellitus
  28. Effects of metabolic control on bone mineral density and markers of bone remodeling in adult patients with type 1 diabetes mellitus
  29. Discrepant GH and IGF-I values in the evaluation of treated acromegalic patients; an ongoing challenge. A meta-analysis
  30. Parameters of glucose and lipid metabolism at the fasted state in drug-naïve first-episode patients with psychosis: Evidence for insulin resistance
  31. Cushing’s Syndrome Due to CRH and ACTH Co-secreting Pancreatic Tumor—Presentation of a New Case Focusing on Diagnostic Pitfalls
  32. Impact of gsp mutations in somatotroph pituitary adenomas on growth hormone response to somatostatin analogs: a meta-analysis
  33. Intensive glycemic control fails to improve indices of vascular dysfunction in patients with type 2 diabetes; results at 6-12 months follow-up
  34. The role of TCF7L2 polymorphism in the development of type 2 diabetes in subjects with metabolic syndrome
  35. Bone mineral density in patients with type 1 diabetes mellitus by DEXA and QCT
  36. Sex steroids levels and body composition in male patients with type 1 diabetes mellitus
  37. The (CAG)n repeat polymorphism of the androgen receptor gene is associated with bone mineral density in menopausal women
  38. THE EMERGING ROLE OF DENOSUMAB IN THE LONG-TERM MANAGEMENT OF PARATHYROID CARCINOMA-RELATED REFRACTORY HYPERCALCEMIA
  39. Impact of gsp mutations in somatotroph pituitary adenomas on growth hormone response to somatostatin analogues: a meta-analysis
  40. Adrenal Reserve Following Treatment of Graves' Orbitopathy with Intravenous Glucocorticoids
  41. Glycaemic control of Type 1 diabetes in clinical practice early in the 21st century: an international comparison
  42. Severe resistant hypoglycemia in a patient with a pancreatic neuroendocrine tumor on sunitinib treatment
  43. Association of the (TAAAA)n repeat polymorphism of SHBG gene with the age at menopause in Greek postmenopausal women
  44. Treatment with dipeptidyl peptidase-4 inhibitors may induce bullous pemphigoid in patients with type 2 diabetes
  45. The -857C/T single-nucleotide polymorphism of TNF[alpha] gene is associated with bone mineral density in Greek peri- and postmenopausal women
  46. Steroid treatment in patients with active moderate-to-severe Graves orbitopathy
  47. Association of the(TTTA)nrepeat polymorphism ofCYP19gene with bone mineral density in Greek peri- and postmenopausal women
  48. Relapsing Episodes of Loss of Consciousness in a Patient With Hepatocellular Carcinoma
  49. Association of the (TTTA)nrepeat polymorphism of CYP19 gene with bone mineral density in Greek peri- and postmenopausal women
  50. Determinants of vascular function in patients with type 2 diabetes
  51. Hypokalemic paralysis following administration of intravenous methylprednisolone in a patient with Graves' thyrotoxicosis and ophthalmopathy
  52. Association of the A1330V and V667M polymorphisms of LRP5 with bone mineral density in Greek peri- and postmenopausal women
  53. A 42 year old man with bilateral exophthalmos and weight loss
  54. Simultaneous Cushing's disease and tuberous sclerosis; a potential role for TSC in pituitary ontogeny
  55. Contribution of Plasma Galactose and Glucose to Milk Lactose Synthesis during Galactose Ingestion
  56. Impact of Duration of Infusion and Choice of Isotope Label on Isotope Recycling in Glucose Homeostasis
  57. Regulation of lipolysis: natriuretic peptides and the development of cachexia
  58. Hexoneogenesis in the Human Breast during Lactation
  59. Metabolic Adaptation to Feeding and Fasting during Lactation in Humans
  60. Metabolic Adaptation to Feeding and Fasting during Lactation in Humans
  61. Is Excessive Weight Gain After Ablative Treatment of Hyperthyroidism due to Inadequate Thyroid Hormone Therapy?